Nightingale Health Cuts Revenue Forecast Following Major Project Delay

About this update from Nightingale Health Oyj Class B

Nightingale Health Oyj OMXHEX:HEALTH:ISSUED ON MONDAY PROFIT WARNINGWILL NOT REACH ITS PREVIOUSLY COMMUNICATED MILESTONE OF MORE THAN 50% REVENUE GROWTH Y/Y FOR THE CURRENT FINANCIAL YEARREASON IS A SHIFT IN THE TIMELINE OF A MAJOR PROJECT ANNOUNCED ON SEPTEMBER 16, 2025, WITH CONTRACT VALUE OF EUR 2.4 MILLIONTIMELINE SHIFT MOVES ABOUT EUR 2 MILLION OF REVENUE INTO THE NEXT FINANCIAL YEARSTILL EXPECTS CURRENT-YEAR REVENUE TO GROW BY ABOUT 20% (+/- 5%) Y/YEXPECTS REVENUE TO EXCEED EUR 10 MILLION IN THE NEXT FINANCIAL YEARTO ANNOUNCE MORE DETAILED TARGETS FOR 2026–2027 AS PART OF FULL-YEAR RESULT RELEASE IN SEPTEMBER 2026Source text for Workspace:Further company coverage:

View stock analysis, news, and events for Nightingale Health Oyj Class B